The metabolic syndrome.
This article provides an overview of the metabolic syndrome, a collection of cardiovascular risk factors that denote a high-risk, multifactorial,adverse cardiovascular state, which is largely the result of obesity and resulting insulin resistance. Treatment for the metabolic syndrome should be focused primarily on modifying lifestyle,with reduction of the underlying obesity and insulin resistance. A combination of chemoprevention and lifestyle modification may prevent many if not most cases of diabetes if treatment is instituted early.
Department of Medicine, Baylor College of Medicine, 6550 Fannin Street, Suite 1045, Houston, TX 77030, USA. agarber@bcm.tmc.edu
Alan J
AJ
Garber
D000328:Adult; D017677:Age Distribution; D000368:Aged; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D015994:Incidence; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D008875:Middle Aged; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D014481:United States / Q000453:epidemiology